New blood pressure-lowering guidelines could benefit 25 million Americans with chronic kidney disease
Latest survey findings indicate significant decline in molecular testing for cancer during COVID-19 pandemic
23 February 2021Researcher develops, tests nano-carrier as potential treatment for glioblastomas
23 February 2021New blood pressure-lowering guidelines could benefit 25 million Americans with chronic kidney disease
A recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in kidney disease could, if followed, benefit nearly 25 million Americans, according to an analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health.
